Risk factor
Very high price volatility
Profitability factor
Undervalued vs peers
About
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional...
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers. Specifically, the stock is 'expensive' on P/E, undervalued on EV/EBITDA, u
Target Price
The average target price of PETS is 2.8 and suggests 10% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation s
Buy
Sell